Increased efficacy and safety of medicinal products and nutraceutics: modern Methods – New Challenges (Q19967): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
Normal rank
 

Revision as of 18:10, 28 October 2020

Project Q19967 in Czech Republic
Language Label Description Also known as
English
Increased efficacy and safety of medicinal products and nutraceutics: modern Methods – New Challenges
Project Q19967 in Czech Republic

    Statements

    0 references
    0 references
    0 references
    180,851,550.5 Czech koruna
    0 references
    7,234,062.02 Euro
    10 January 2020
    0 references
    212,766,530.0 Czech koruna
    0 references
    8,510,661.2 Euro
    10 January 2020
    0 references
    85 percent
    0 references
    1 January 2018
    0 references
    31 December 2022
    0 references
    Univerzita Karlova
    0 references
    0 references

    50°5'20.22"N, 14°25'13.04"E
    0 references

    50°5'7.01"N, 14°25'23.81"E
    0 references
    11000
    0 references
    Projekt EFSA-CDN podpoří excelentní interdisciplinární výzkum na FaF UK s potenciálem tvorby kvalitních aplikovaných výsledků v delším časovém horizontu. Jeho cílem je zvýšit účinnost a bezpečnost léčiv a nutraceutik a zvýšit konkurenceschopnost VaV centra v mezinárodním měřítku, a to realizací klíčových aktivit podporujících kvalitní výzkum, rozvoj výzkumných týmů s účastí excelentních zahraničních vědců, modernizaci infrastruktury, internacionalizaci a řízení projektu ve všech jeho fázích. a. (Czech)
    0 references
    The EFSA-CDN project will support excellent interdisciplinary research at the UK FaF with the potential to produce quality applied results over the longer term. Its aim is to increase the effectiveness and safety of pharmaceuticals and nutraceutics and to increase the competitiveness of the R & D Centre internationally by implementing key activities supporting quality research, developing research teams with the participation of excellent foreign scientists, infrastructure modernisation, internationalisation and project management at all its stages. and. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.02.1.01/0.0/0.0/16_019/0000841
    0 references